Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 1
2015 6
2016 8
2017 13
2018 18
2019 15
2020 4
2021 7
2022 13
2023 10
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Poverty and inequality in real-world schizophrenia: a national study.
Fond GB, Yon DK, Tran B, Mallet J, Urbach M, Leignier S, Rey R, Misdrahi D, Llorca PM, Schürhoff F, Berna F, Boyer L. Fond GB, et al. Among authors: urbach m. Front Public Health. 2023 Oct 31;11:1182441. doi: 10.3389/fpubh.2023.1182441. eCollection 2023. Front Public Health. 2023. PMID: 38026279 Free PMC article.
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F, Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Fond G, et al. Among authors: urbach m. BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. BMJ Ment Health. 2023. PMID: 37852631 Free PMC article.
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Fond G, Godin O, Schürhoff F, Berna F, André M, Aouizerate B, Capdevielle D, Chereau I, D' Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Pignon B, Rey R, Szoke A, Urbach M, Vidailhet P, Leboyer M, Boyer L, Llorca PM; FACE-SZ group. Fond G, et al. Among authors: urbach m. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109927. doi: 10.1016/j.pnpbp.2020.109927. Epub 2020 Mar 12. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32173456 Review.
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Leignier S, Llorca PM, Lançon C, Mallet J, Passerieux C, Pignon B, Rey R, Schürhoff F, Swendsen J, Urbach M, Szöke A, Godin O, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Misdrahi D, et al. Among authors: urbach m. Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
Handedness as a neurodevelopmental marker in schizophrenia: Results from the FACE-SZ cohort.
Mallet J, Godin O, Le Strat Y, Mazer N, Berna F, Boyer L, Capdevielle D, Clauss J, Chéreau I, D'Amato T, Dubreucq J, Leigner S, Llorca PM, Misdrahi D, Passerieux C, Rey R, Pignon B, Urbach M, Schürhoff F, Fond G, Dubertret C; FACE-SZ (FondaMental Academic Center of Expertise for Schizophrenia Group). Mallet J, et al. Among authors: urbach m. World J Biol Psychiatry. 2022 Sep;23(7):525-536. doi: 10.1080/15622975.2021.2013094. Epub 2021 Dec 17. World J Biol Psychiatry. 2022. PMID: 34918618
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia.
Roux P, Faivre N, Urbach M, Aouizerate B, Brunel L, Capdevielle D, Chereau I, Dubertret C, Dubreucq J, Fond G, Lançon C, Leignier S, Mallet J, Misdrahi D, Pires S, Schneider P, Schurhoff F, Yazbek H, Zinetti-Bertschy A, Passerieux C, Brunet-Gouet E. Roux P, et al. Among authors: urbach m. Schizophr Res. 2023 Feb;252:48-55. doi: 10.1016/j.schres.2022.12.037. Epub 2023 Jan 7. Schizophr Res. 2023. PMID: 36623435
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia.
Korchia T, Tastevin M, Sunhary de Verville PL, Joober R, Andrieu-Haller C, Faugere M, Godin O, Etchecopar-Etchart D, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, Dorey JM, Dubertret C, Dubreucq J, Mallet J, Misdrahi D, Passerieux C, Rey R, Schürhoff F, Szoke A, Urbach M, Leboyer M, Llorca PM, Lançon C, Richieri R, Boyer L, Fond G. Korchia T, et al. Among authors: urbach m. World J Biol Psychiatry. 2022 Nov;23(9):703-714. doi: 10.1080/15622975.2022.2031286. Epub 2022 Feb 1. World J Biol Psychiatry. 2022. PMID: 35057713
The puzzle of quality of life in schizophrenia: putting the pieces together with the FACE-SZ cohort.
Ehrminger M, Roux P, Urbach M, André M, Aouizerate B, Berna F, Bohec AL, Capdevielle D, Chéreau I, Clauss J, Dubertret C, Dubreucq J, Fond G, Honciuc RM, Lançon C, Laouamri H, Leigner S, Mallet J, Misdrahi D, Pignon B, Rey R, Schürhoff F; Members of the FACE-SCZ Group; Passerieux C, Brunet-Gouet E. Ehrminger M, et al. Among authors: urbach m. Psychol Med. 2022 Jun;52(8):1501-1508. doi: 10.1017/S0033291720003311. Epub 2020 Sep 23. Psychol Med. 2022. PMID: 32962773
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
Godin O, Pignon B, Szoke A, Boyer L, Aouizerate B, Schorr B, André M, Capdevielle D, Chereau I, Coulon N, Dassing R, Dubertret C, Etain B, Leignier S, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Urbach M, Schürhoff F, Leboyer M, Fond G. Godin O, et al. Among authors: urbach m. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110641. doi: 10.1016/j.pnpbp.2022.110641. Epub 2022 Sep 17. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36122839
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. Among authors: urbach m. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
77 results